Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4932)
All Articles published online
|
Oct 21, 2012 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lim JY, Yoon SO, Hong SW, Kim JW, Choi SH, Cho JY. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence. World J Gastroenterol 2012; 18(39): 5581-5588 [PMID: 23112551 DOI: 10.3748/wjg.v18.i39.5581] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v18/i39/5581.htm |
| Number | Citing Articles |
| 1 |
Farideh Kamarehei, Massoud Saidijam, Amir Taherkhani. Prognostic biomarkers and molecular pathways mediating Helicobacter pylori–induced gastric cancer: a network-biology approach. Genomics & Informatics 2023; 21(1): e8 doi: 10.5808/gi.22072
|
| 2 |
Fariba Mohammadi, Arash Soltani, Atefeh Ghahremanloo, Hossein Javid, Seyed Isaac Hashemy. The thioredoxin system and cancer therapy: a review. Cancer Chemotherapy and Pharmacology 2019; 84(5): 925 doi: 10.1007/s00280-019-03912-4
|
| 3 |
Jonathan Muri, Manfred Kopf. The thioredoxin system: Balancing redox responses in immune cells and tumors. European Journal of Immunology 2023; 53(1) doi: 10.1002/eji.202249948
|
| 4 |
Theresa D Ahrens, Sylvia Timme, Jenny Ostendorp, Lioudmilla Bogatyreva, Jens Hoeppner, Ulrich T Hopt, Dieter Hauschke, Martin Werner, Silke Lassmann. Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity. Laboratory Investigation 2016; 96(3): 307 doi: 10.1038/labinvest.2015.148
|
| 5 |
Fuyu Li, Wenlong Ming, Wenxiang Lu, Ying Wang, Xiaohan Li, Xianjun Dong, Yunfei Bai. FLED: a full-length eccDNA detector for long-reads sequencing data. Briefings in Bioinformatics 2023; 24(6) doi: 10.1093/bib/bbad388
|
| 6 |
Hiroshi Masutani. Thioredoxin-Interacting Protein in Cancer and Diabetes. Antioxidants & Redox Signaling 2022; 36(13-15): 1001 doi: 10.1089/ars.2021.0038
|
| 7 |
Qian Sun, Bi‐Bo Wang, Wei Wei, Gui‐Chun Huang, Lei‐Lei Liu, Wei‐Wei Chen, Jing Wang, Xiao‐Yue Zhao, Lu Lu, Rong Fang, Chun‐Yan Zhu, Xiao‐Yuan Chu. ITCH facilitates proteasomal degradation of TXNIP in hypoxia‐ induced lung cancer cells. Thoracic Cancer 2022; 13(15): 2235 doi: 10.1111/1759-7714.14552
|
| 8 |
Bo Ra You, Hye Rim Shin, Bo Ram Han, Woo Hyun Park. PX-12 induces apoptosis in Calu-6 cells in an oxidative stress-dependent manner. Tumor Biology 2015; 36(3): 2087 doi: 10.1007/s13277-014-2816-x
|
| 9 |
Erika Seki Kioshima, Patrícia de Souza Bonfim de Mendonça, Marcus de Melo Teixeira, Isis Regina Grenier Capoci, André Amaral, Franciele Abigail Vilugron Rodrigues-Vendramini, Bruna Lauton Simões, Ana Karina Rodrigues Abadio, Larissa Fernandes Matos, Maria Sueli Soares Felipe. One Century of Study: What We Learned about Paracoccidioides and How This Pathogen Contributed to Advances in Antifungal Therapy. Journal of Fungi 2021; 7(2): 106 doi: 10.3390/jof7020106
|
| 10 |
Xiyao Yin, Xin Liu, Hui Gong, Zhiliang Chu. LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling. Journal of Gynecologic Oncology 2024; 35 doi: 10.3802/jgo.2024.35.e97
|
| 11 |
HYE RIM SHIN, BO RA YOU, WOO HYUN PARK. PX-12-induced HeLa cell death is associated with oxidative stress and GSH depletion. Oncology Letters 2013; 6(6): 1804 doi: 10.3892/ol.2013.1637
|
| 12 |
BO RA YOU, HYE RIM SHIN, WOO HYUN PARK. PX-12 inhibits the growth of A549 lung cancer cells via G2/M phase arrest and ROS-dependent apoptosis. International Journal of Oncology 2014; 44(1): 301 doi: 10.3892/ijo.2013.2152
|
| 13 |
Sewha Kim, Do Hee Kim, Woo Hee Jung, Ja Seung Koo. The expression of redox proteins in phyllodes tumor. Breast Cancer Research and Treatment 2013; 141(3): 365 doi: 10.1007/s10549-013-2701-0
|
| 14 |
Gaopan Dong, Xiaohan Ye, Shumei Wang, Wenhua Li, Rong Cai, Lupei Du, Xiaodong Shi, Minyong Li. Au-24 as a potential thioredoxin reductase inhibitor in hepatocellular carcinoma cells. Pharmacological Research 2022; 177: 106113 doi: 10.1016/j.phrs.2022.106113
|
| 15 |
Chuangyu Wen, Huihui Wang, Xiaobin Wu, Lu He, Qian Zhou, Fang Wang, Siyu Chen, Lanlan Huang, Junxiong Chen, Huashe Wang, Weibiao Ye, Wende Li, Xiangling Yang, Huanliang Liu, Junsheng Peng. ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin. Cell Death & Disease 2019; 10(11) doi: 10.1038/s41419-019-2035-x
|
| 16 |
Wenjing Shang, Zhongdong Xie, Fengying Lu, Daoquan Fang, Tianbin Tang, Ruichun Bi, Lingli Chen, Lei Jiang. Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/9291683
|
| 17 |
Min Pan, Fengping Zhang, Kai Qu, Chang Liu, Jingyao Zhang, Ziwei Zhang. TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/7805115
|
| 18 |
Woo Hyun Park. Upregulated thioredoxin and its reductase prevent H2O2-induced growth inhibition and death in human pulmonary artery smooth muscle cells. Toxicology in Vitro 2019; 61: 104590 doi: 10.1016/j.tiv.2019.104590
|
| 19 |
Ting Liu, Li Sun, Yubin Zhang, Yonglin Wang, Jiang Zheng. Imbalanced GSH/ROS and sequential cell death. Journal of Biochemical and Molecular Toxicology 2022; 36(1) doi: 10.1002/jbt.22942
|
| 20 |
Gang Li, Kun Gao, Yuan Chi, Xiling Zhang, Takahiko Mitsui, Jian Yao, Masayuki Takeda. Upregulation of connexin43 contributes to PX-12-induced oxidative cell death. Tumor Biology 2016; 37(6): 7535 doi: 10.1007/s13277-015-4620-7
|
| 21 |
Blake R Wilde, Zhizhou Ye, Tian-Yeh Lim, Donald E Ayer. Cellular acidosis triggers human MondoA transcriptional activity by driving mitochondrial ATP production. eLife 2019; 8 doi: 10.7554/eLife.40199
|
| 22 |
Xia Ying Cui, Sun Hyang Park, Woo Hyun Park. Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels. Molecules 2022; 27(16): 5207 doi: 10.3390/molecules27165207
|
| 23 |
Emma Purcell, Zeqi Niu, Sarah Owen, Madeline Grzesik, Abigail Radomski, Anna Kaehr, Nna-Emeka Onukwugha, Heather Fairbairn Winkler, Nithya Ramnath, Theodore Lawrence, Shruti Jolly, Sunitha Nagrath. Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy. Cell Reports 2024; 43(2): 113687 doi: 10.1016/j.celrep.2024.113687
|
| 24 |
Dilinaer Wusiman, Wenbin Li, Lei Guo, Zehao Huang, Yi Zhang, Xiwei Zhang, Xiaohui Zhao, Lin Li, Zhaohong An, Zhengjiang Li, Jianming Ying, Changming An. Comprehensive analysis of single-cell and bulk RNA-sequencing data identifies B cell marker genes signature that predicts prognosis and analysis of immune checkpoints expression in head and neck squamous cell carcinoma. Heliyon 2023; 9(12): e22656 doi: 10.1016/j.heliyon.2023.e22656
|
| 25 |
FULE WANG, FEIYAN LIN, PEILI ZHANG, WUHUA NI, LAIXI BI, JIANBO WU, LEI JIANG. Thioredoxin-1 inhibitor, 1-methylpropyl 2-imidazolyl disulfide, inhibits the growth, migration and invasion of colorectal cancer cell lines. Oncology Reports 2015; 33(2): 967 doi: 10.3892/or.2014.3652
|
| 26 |
Farah H. Abdalbari, Carlos M. Telleria. The gold complex auranofin: new perspectives for cancer therapy. Discover Oncology 2021; 12(1) doi: 10.1007/s12672-021-00439-0
|
| 27 |
Mina Noura, Hidemasa Matsuo, Asami Koyama, Souichi Adachi, Hiroshi Masutani. TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells. FEBS Open Bio 2020; 10(8): 1532 doi: 10.1002/2211-5463.12908
|
| 28 |
Shin Yee Hong, Thilo Hagen. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation – Implications for targeting the Warburg effect in cancer cells. Biochemical and Biophysical Research Communications 2015; 465(4): 838 doi: 10.1016/j.bbrc.2015.08.097
|
| 29 |
Sebastian Lampe, Michael Kunze, Anica Scholz, Thilo F. Brauß, Sofia Winslow, Stefan Simm, Mario Keller, Juliana Heidler, Ilka Wittig, Bernhard Brüne, Tobias Schmid. Identification of the TXNIP IRES and characterization of the impact of regulatory IRES trans-acting factors. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2018; 1861(2): 147 doi: 10.1016/j.bbagrm.2018.01.010
|
| 30 |
Caroline M. Woolston, Srinivasan Madhusudan, Irshad N. Soomro, Dileep N. Lobo, Alexander M. Reece-Smith, Simon L. Parsons, Stewart G. Martin. Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma. Redox Biology 2013; 1(1): 285 doi: 10.1016/j.redox.2013.04.006
|
| 31 |
Tianyu Zhu, Zhihao Hu, Zhuoyin Wang, Hengxuan Ding, Ruixin Li, Jingtao Wang, Guojun Wang. microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells. Cell Biology and Toxicology 2023; 39(5): 1923 doi: 10.1007/s10565-021-09675-0
|
| 32 |
Rosanna Lucignano, Alessandro Pratesi, Paola Imbimbo, Daria Maria Monti, Delia Picone, Luigi Messori, Giarita Ferraro, Antonello Merlino. Evaluation of Auranofin Loading within Ferritin Nanocages. International Journal of Molecular Sciences 2022; 23(22): 14162 doi: 10.3390/ijms232214162
|
| 33 |
Jennifer A Morrison, Laura A Pike, Sharon B Sams, Vibha Sharma, Qiong Zhou, Jill J Severson, Aik-Choon Tan, William M Wood, Bryan R Haugen. Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer. Molecular Cancer 2014; 13(1): 62 doi: 10.1186/1476-4598-13-62
|
| 34 |
Yiting Chen, Jieling Ning, Wenjie Cao, Shuanglian Wang, Tao Du, Jiahui Jiang, Xueping Feng, Bin Zhang. Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.568574
|
| 35 |
Morana Jaganjac, Lidija Milkovic, Suzana Borovic Sunjic, Neven Zarkovic. The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies. Antioxidants 2020; 9(11): 1151 doi: 10.3390/antiox9111151
|
| 36 |
Fadime Aydın Köse, Aysun Pabuccuoglu, Miray Karakoyun, Sema Aydogdu. Peroxiredoxins and Hypoxia-Inducible Factor-1α in Duodenal Tissue: Emerging Factors in the Pathophysiology of Pediatric Celiac Disease Patients. Current Issues in Molecular Biology 2023; 45(2): 1779 doi: 10.3390/cimb45020114
|
| 37 |
Barak Rotblat, Thomas G. P. Grunewald, Gabriel Leprivier, Gerry Melino, Richard A. Knight. Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers. Oncotarget 2013; 4(12): 2577 doi: 10.18632/oncotarget.1658
|
| 38 |
Tanusree Roy. Analysis of cancer gene attributes using electrical sensor. Gene 2019; 685: 62 doi: 10.1016/j.gene.2018.10.073
|
| 39 |
Joana Schröder, Udo Schumacher, Lukas Clemens Böckelmann. Thioredoxin Interacting Protein (TXNIP) Is Differentially Expressed in Human Tumor Samples but Is Absent in Human Tumor Cell Line Xenografts: Implications for Its Use as an Immunosurveillance Marker. Cancers 2020; 12(10): 3028 doi: 10.3390/cancers12103028
|
| 40 |
Tina Oberacker, Leonie Kraft, Moritz Schanz, Jörg Latus, Severin Schricker. The Importance of Thioredoxin-1 in Health and Disease. Antioxidants 2023; 12(5): 1078 doi: 10.3390/antiox12051078
|
| 41 |
Shimaa A. Abass, Nabil M. Abdel-Hamid, Tarek K. Abouzed, Mamdouh Mohammad El-Shishtawy. Chemosensitizing effect of Alpinia officinarum rhizome extract in cisplatin-treated rats with hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2018; 101: 710 doi: 10.1016/j.biopha.2018.02.128
|
| 42 |
A. Mollbrink, R. Jawad, A. Vlamis-Gardikas, P. Edenvik, B. Isaksson, O. Danielsson, P. Stål, A.P. Fernandes. Expression of Thioredoxins and Glutaredoxins in Human Hepatocellular Carcinoma: Correlation to Cell Proliferation, Tumor Size and Metabolic Syndrome. International Journal of Immunopathology and Pharmacology 2014; 27(2): 169 doi: 10.1177/039463201402700204
|
| 43 |
Leonardo Lisboa da Motta, Marco Antonio De Bastiani, Fernanda Stapenhorst, Fábio Klamt. Oxidative stress associates with aggressiveness in lung large-cell carcinoma. Tumor Biology 2015; 36(6): 4681 doi: 10.1007/s13277-015-3116-9
|